blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Popular
Elections

Genius — OpenServe

Sponsored

Alasdair Coles — latest news, discussion & facts — IJR

Alasdair Coles

neuroimmunologist

Alasdair Coles

British neuroimmunologist

Ask Genius Site

Feed Discussions About

About Alasdair Coles

Also known as Alasdair John Coles

About Alasdair Coles

British neuroimmunologist

0

members

Occupation: neuroimmunologist, university teacher
Citizenship: United Kingdom
Born: November 18, 1966

Everything about Alasdair Coles →

Facts from Wikidata (CC0).

Related journals

Family

John Coles Anne Mary Sutherland Graham

Connected

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis Alemtuzumab Therapy for Multiple Sclerosis Immune competence after alemtuzumab treatment of multiple sclerosis MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosis Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis Alemtuzumab Treatment of Multiple Sclerosis University of Cambridge United Kingdom

Occupation: neuroimmunologist, university teacher
Citizenship: United Kingdom
Born: November 18, 1966

Family

John Colesfather Anne Mary Sutherland Grahammother

Related

Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trialknown for A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosisknown for Alemtuzumab Therapy for Multiple Sclerosisknown for

Immune competence after alemtuzumab treatment of multiple sclerosis

known for

MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequencesknown for

Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosisknown for

Predicting autoimmunity after alemtuzumab treatment of multiple sclerosisknown for

Alemtuzumab Treatment of Multiple Sclerosisknown for

University of Cambridgeemployer

United Kingdomcountry of citizenship